| Sales | 148.66M |
| Cost of products sold | 130.57M |
| Restructuring charges | |
| Gross profit | 18.01M |
| Research and development | 1.38M |
| Selling, general and administrative | 13.82M |
| Restructuring charges | 221K |
| Total operating expenses | 15.42M |
| Operating income (loss) | 2.59M |
| Interest expense | -112K |
| Interest and other income (expense) | |
| Total other income (expense) | 39K |
| Loss before taxes | |
| Taxes | -113K |
| Net loss from continuing operations | |
| Net loss from discontinued operations | |
| Net loss | 2.75M |
| Loss from continuing operations (in Dollars per share) | |
| Loss from discontinued operations (in Dollars per share) | |
| (in Dollars per share) | 0.08 |
| Loss from continuing operations (in Dollars per share) | |
| Loss from discontinued operations (in Dollars per share) | |
| (in Dollars per share) | 0.08 |
| Basic weighted average common shares outstanding (in Shares) | 34.44M |
| Diluted weighted average common shares outstanding (in Shares) | 34.44M |